- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03115723
Analysis of Hospitalizations One Year After Acts of CAG and PCI in the Aquitaine région - ACIRA Register Data Analysis (ACIRA-REHOSP)
February 8, 2022 updated by: University Hospital, Bordeaux
Frequency and Characteristics of Rehospitalizations During One Year After Percutaneous Coronary Intervention and Coronary Angiography - Results of the ACIRA Registry, Aquitaine Region
Hospital readmission rate following percutaneous coronary interventions (PCI) or coronary angiographies (CAG) is a main indicator of quality of care and addresses economic issues.
The aim of this study is to quantify the frequency and analyse the types of rehospitalizations and repeat revascularizations during one year after a PCI or a CAG.
This information is needed to organize the health care pathway and to identify preventable rehospitalizations.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
11487
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Agen, France
- Clinique Esquirol St Hilaire
-
Aressy, France
- Clinique cardiologique d'Aressy
-
Bayonne, France
- GCS Bayonne
-
Bordeaux, France
- Clinique de Caudéran les pins-francs
-
Bordeaux, France
- Clinique de St Augustin
-
Libourne, France
- CH de Libourne
-
Mont de Marsan, France
- CH De Mont de Marsan
-
Pau, France
- CH de Pau
-
Perigueux, France
- CH de Périgueux
-
Pessac, France, 33604
- CHU de Bordeaux
-
Pessac, France
- Hôpital Privé St Martin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All volunteer adults (≥ 18 years) and French resident patients who underwent PCI and CAG in nine interventional cardiology hospitals in the Aquitaine region (France), from January 1, 2012 to December 31, 2013.
Description
Inclusion Criteria:
- Patients included in ACIRA Registry : All volunteer adults (≥ 18 years) and French resident patients who underwent PCI and CAG in the interventional cardiology hospitals in the Aquitaine region (France),
- Initial PCI or CAG performed from January 1, 2012 to December 31, 2013,
- Initial PCI or CAG performed in nine interventional cardiology hospitals in the Aquitaine region (France).
Exclusion Criteria:
- Patients who declined to take part of ACIRA Registry,
- Patients resident outside the Aquitaine region (France),
- Patients who died during the initial hospital stay,
- Patients hospitalized for a PCI or a CAG the month preceding the initial procedure including in the ACIRA-Rehosp study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1 : Percutaneous coronary intervention
All the patients who underwent percutaneous coronary intervention, in 9 invasive cardiology centers in the Aquitaine Region, France.
|
|
|
Group 2 : Coronary angiography
All the patients who underwent coronary angiography, in 9 invasive cardiology centers in the Aquitaine Region, France
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Type of rehospitalization
Time Frame: Baseline to 1 year
|
Baseline to 1 year
|
|
Number of rehospitalization
Time Frame: Baseline to 1 year
|
Baseline to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of hospitals
Time Frame: Baseline to 1 year
|
All hospitals concerned by initial coverage and rehospitalization
|
Baseline to 1 year
|
|
Type of diagnoses and procedures associated with each type of rehospitalization
Time Frame: Baseline to 1 year
|
Baseline to 1 year
|
|
|
Type of cardiac rehabilitation procedures in hospitalizations for post-operative and rehabilitation wards
Time Frame: Baseline to 1 year
|
Baseline to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Saillour-Glénisson Florence, MD, University Hospital, Bordeaux
- Study Director: Lesaine Emilie, MD, University Hospital, Bordeaux
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2016
Primary Completion (Actual)
January 15, 2017
Study Completion (Actual)
January 15, 2017
Study Registration Dates
First Submitted
April 10, 2017
First Submitted That Met QC Criteria
April 10, 2017
First Posted (Actual)
April 14, 2017
Study Record Updates
Last Update Posted (Actual)
February 9, 2022
Last Update Submitted That Met QC Criteria
February 8, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- CHUBX 2014/29
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Angiography
-
Baylor Research InstituteCompletedCoronary Angioplasty | Coronary AngiographyUnited States
-
Hillel Yaffe Medical CenterUnknown
-
Ospedale Sandro Pertini, RomaCompletedPercutaneous Coronary Intervention | Coronary AngiographyItaly
-
Fundación Pública Andaluza Progreso y SaludHospital Universitario Reina Sofia de CordobaCompletedCoronary AngiographySpain
-
Meir Medical CenterCompletedCoronary AngiographyIsrael
-
Yuksek Ihtisas UniversityNot yet recruitingCoronary Angiography (CAG)Turkey
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompletedCoronary AngiographyFrance
-
University of FloridaCompletedCoronary AngiographyUnited States
Clinical Trials on Percutaneous coronary intervention
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedCoronary Artery DiseaseChina
-
University Hospital, SaarlandCompletedAcute Myocardial InfarctionGermany
-
University Hospital of PatrasCompletedCoronary Artery Bypass SurgeryGreece
-
Yonsei UniversityUnknownCoronary Artery Disease | Stable Angina | Unstable AnginaKorea, Republic of
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
RobocathCompletedCoronary Artery Disease | Percutaneous Coronary InterventionFrance, Belgium, Luxembourg, Netherlands
-
University College, LondonNational Institute for Cardiovascular Outcomes Research; British Cardiovascular... and other collaboratorsCompletedPercutaneous Coronary InterventionUnited Kingdom
-
Herlev and Gentofte HospitalUnknownCoronary Heart Disease | Ischemic Heart Disease | Stable AnginaDenmark
-
Philips Clinical & Medical Affairs GlobalCompletedCoronary Artery DiseaseIsrael, United States, Belgium, Spain
-
Corindus Inc.CompletedMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesUnited States, Israel